Clinical Trial

MenoZen VR for Menopause Symptom Management: Phase 2

Name: MenoZen VR for Menopause Symptom Management: Phase 2 — clinical trial record (NCT07633743)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this research is to evaluate the feasibility, acceptability, tolerability, and clinical efficacy of MenoZen VR (virtual reality) for managing menopause symptoms in women.

Trial Details

NCT Number	NCT07633743
Lead Sponsor	Mayo Clinic
Conditions	Menopause
Enrollment	40 participants
Start Date	2026-07-31
Primary Completion	2027-07-31 (estimated)
Study Completion	2028-07-31 (estimated)
Updated on ClinicalTrials.gov	2026-06-08